These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2634884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Associations of HLA-DR 4, DR 2, DRw 9 with clinical findings in rheumatoid arthritis].
    Watanabe I, Taneichi K, Shibaki H.
    Ryumachi; 1989 Feb; 29(1):39-44. PubMed ID: 2787056
    [Abstract] [Full Text] [Related]

  • 3. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C, Boki K, Varla-Leftherioti M, Kappos-Rigatou I, Fostiropoulos G, Economidou J.
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [Abstract] [Full Text] [Related]

  • 4. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ, Ament BJ, Feltkamp BW, van der Korst JK.
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J, Van Wanghe P, Verdickt W.
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [Abstract] [Full Text] [Related]

  • 8. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
    Barrera P, Balsa A, Alves H, Westhovens R, Maenaut K, Cornélis F, Fritz P, Bardin T, Ceu Maia M, Lopes-Vaz A, Pascual Salcedo D, de la Concha E, Radstake T, van de Putte LB, Migliorini P, Prudhomme JF, Charron D, Spyropoulou M, Mendes A, Spaepen M, Martinez M, Stavropoulos C, European Consortium on Rheumatoid Arthritis Families.
    J Rheumatol; 2001 May; 28(5):968-74. PubMed ID: 11361224
    [Abstract] [Full Text] [Related]

  • 9. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD, Anhorn KA.
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [Abstract] [Full Text] [Related]

  • 10. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ.
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [Abstract] [Full Text] [Related]

  • 11. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F, Reekers P, van de Putte LB, Vandenbroucke JP, Rasker JJ, de Rooij DJ.
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [Abstract] [Full Text] [Related]

  • 12. [Cross reactions of HLA A and B antigens in 63 patients with rheumatoid arthritis].
    Dreyfus P, Geay D, Cambon H, Daupleix D.
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):197-202. PubMed ID: 6587517
    [Abstract] [Full Text] [Related]

  • 13. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A, Lacaille D, Horne C, Chalmers A, Hoar DI, Balshaw R, Keown PA.
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [Abstract] [Full Text] [Related]

  • 14. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.
    Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
    [Abstract] [Full Text] [Related]

  • 15. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis.
    Gran JT, Husby G, Thorsby E.
    J Rheumatol; 1984 Apr; 11(2):136-40. PubMed ID: 6610047
    [Abstract] [Full Text] [Related]

  • 16. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 Apr; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 17. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR, Idle JR, Smith RL, Waring RH.
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [Abstract] [Full Text] [Related]

  • 18. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility.
    López-Arbesu R, Ballina-García FJ, Alperi-López M, López-Soto A, Rodríguez-Rodero S, Martínez-Borra J, López-Vázquez A, Fernández-Morera JL, Riestra-Noriega JL, Queiro-Silva R, Quiñones-Lombraña A, López-Larrea C, González S.
    Rheumatology (Oxford); 2007 Mar; 46(3):426-30. PubMed ID: 17003176
    [Abstract] [Full Text] [Related]

  • 19. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
    Kapitány A, Zilahi E, Szántó S, Szücs G, Szabó Z, Végvári A, Rass P, Sipka S, Szegedi G, Szekanecz Z.
    Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
    [Abstract] [Full Text] [Related]

  • 20. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G, Szekanecz Z, Zilahi E, Kapitány A, Baráth S, Szamosi S, Végvári A, Szabó Z, Szántó S, Czirják L, György Kiss C.
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.